Urinary Citrate Levels Do Not Correlate with Urinary pH in Patients with Urinary Stone Formation

Urology

Volumn 70, Issue 4, 2007, Pages 634-637

  Whitson, Jared M ^a   Cooperberg, Matthew R ^a   Stackhouse, G Bennett ^a   Stoller, Marshall L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CITRIC ACID; HYDROCHLOROTHIAZIDE;

ADULT; AGED; ALKALINIZATION; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STONE FORMATION; URINALYSIS; URINARY EXCRETION; URINE PH; UROLITHIASIS;

AGED; ALKALIES; ALLOPURINOL; CITRATES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; POTASSIUM CITRATE; URINARY CALCULI; URINE;

EID: 35649013196     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.04.052     Document Type: Article

References (19)

1. Barcelo P., Wuhl O., Servitge E., et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150 (1993) 1761-1764
2. Hofbauer J., Hobarth K., Szabo N., et al. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis-a prospective randomized study. Br J Urol 73 (1994) 362-365
3. Ettinger B., Pak C.Y., Citron J.T., et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158 (1997) 2069-2073
4. Hobarth K., Hofbauer J., and Szabo N. Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology 44 (1994) 20-25
5. Abdulhadi M.H., Hall P.M., and Streem S.B. Can citrate therapy prevent nephrolithiasis?. Urology 41 (1993) 221-224
6. Whalley N.A., Meyers A.M., Martins M., et al. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 78 (1996) 10-14
7. Meyer J.L., and Smith L.H. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 13 (1975) 36-39
8. Greenwald I. The dissociation of calcium salts. J Biol Chem 124 (1938) 437-452
9. Nicar M.J., Hill K., and Pak C.Y. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro. J Bone Miner Res 2 (1987) 215-220
10. Simpson D.P. Citrate excretion: a window on renal metabolism. Am J Physiol 244 (1983) F223-F234
11. Sherman C.C., Mendel L.B., and Smith A.H. The metabolism of orally administered citric acid. J Biol Chem 113 (1936) 265-271
12. Crawford M.A., Milne M.D., and Scribner B.H. The effects of changes in acid-base balance on urinary citrate in the rat. J Physiol 149 (1959) 413-423
13. Martensson J. On the citric acid metabolism in mammals. Acta Physiol Scand 1 (1940) 52-68
14. Siener R., Schade N., Nicolay C., et al. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol 173 (2005) 1601-1605
15. Meschi T., Maggiore U., Fiaccadori E., et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 66 (2004) 2402-2410
16. Schwille P.O., Herrmann U., Wolf C., et al. Citrate and recurrent idiopathic calcium urolithiasis: a longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients. Urol Res 20 (1992) 145-155
17. Jendle-Bengten C., and Tiselius H.G. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34 (2000) 36-41
18. Pak C.Y., and Peterson R. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med 146 (1986) 863-867
19. Pak C.Y., Sakhaee K., and Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 30 (1986) 422-428